← 返回列表 › SCI 期刊 › 医学 › J of Extracellular Vesicle

Journal of Extracellular Vesicles

J of Extracellular Vesicle

ISSN 2001-3078
SCIE Q1 新锐1区 Top期刊 开放获取 医学
影响因子 2026
21.7
↑ 7.2
5年均分
17.007
5-Year IF
H 指数
170
H-Index
年发文量
184
Articles / Year
出刊频率
Continuously Published
Pub. Frequency
创刊年份
1999
Founded Year
出版商
Wiley
Publisher
出版国家
Sweden
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 2.3 个月
💰 版面费用
★★★★★
系统
暂无
官方APC $4,200 USD 约¥30,450
中科院分区
2026新锐分区 新体系
大类1区
医学Medicine
小类1区
细胞生物学Cell Biology
中科院2025年分区 传统体系
大类1区
医学Medicine
小类2区
细胞生物学Cell Biology
Scopus 指标
CiteScore
24.6
综合引用得分
SJR
3.639 Q1
SCImago Journal Rank
SNIP
2.843
Source Normalized Impact
JCI
2.23
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

The Journal of Extracellular Vesicles (JE&V) is the premier international, peer-reviewed, open-access journal dedicated to the rapidly advancing field of extracellular vesicle (EV) research. Published under the Taylor & Francis Group on behalf of the International Society for Extracellular Vesicles (ISEV), the journal serves as the leading platform for disseminating high-impact discoveries related to the biology, function, and clinical applications of exosomes, microvesicles, and other membrane-derived particles. Its scope encompasses a broad range of topics including EV biogenesis, cargo sorting and trafficking, intercellular communication in health and disease, and the development of novel isolation, characterization, and imaging methodologies. The journal also emphasizes translational research, covering the use of EVs as diagnostic biomarkers, therapeutic delivery vehicles, and targets for intervention in conditions such as cancer, neurodegenerative disorders, cardiovascular disease, and infectious diseases. JE&V primarily publishes original research articles, comprehensive reviews, and position papers from ISEV task forces that establish best practices and methodological standards for the field. The target audience includes cell and molecular biologists, biochemists, clinical researchers, and bioengineers working at the intersection of basic science and clinical translation. With a 2026 Impact Factor of 17.3370 and ranking in the JCR Q1 tier, JE&V is widely recognized as the foremost journal in its niche, reflecting its exceptional citation influence and its critical role in shaping the rigor, reproducibility, and future direction of extracellular vesicle science.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.